The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji-Eun | - |
dc.contributor.author | Kim, Jin-Sun | - |
dc.contributor.author | Jo, Min-Jee | - |
dc.contributor.author | Cho, Eunjung | - |
dc.contributor.author | Ahn, Shin-Young | - |
dc.contributor.author | Kwon, Young-Joo | - |
dc.contributor.author | Ko, Gang-Jee | - |
dc.date.accessioned | 2022-08-14T10:43:03Z | - |
dc.date.available | 2022-08-14T10:43:03Z | - |
dc.date.created | 2022-08-12 | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 1420-3049 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/143143 | - |
dc.description.abstract | Metabolic syndrome is a cluster of metabolic indicators that increase the risk of diabetes and cardiovascular diseases. Visceral obesity and factors derived from altered adipose tissue, adipokines, play critical roles in the development of metabolic syndrome. Although the adipokines leptin and adiponectin improve insulin sensitivity, others contribute to the development of glucose intolerance, including visfatin, fetuin-A, resistin, and plasminogen activator inhibitor-1 (PAI-1). Leptin and adiponectin increase fatty acid oxidation, prevent foam cell formation, and improve lipid metabolism, while visfatin, fetuin-A, PAI-1, and resistin have pro-atherogenic properties. In this review, we briefly summarize the role of various adipokines in the development of metabolic syndrome, focusing on glucose homeostasis and lipid metabolism. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, Shin-Young | - |
dc.contributor.affiliatedAuthor | Kwon, Young-Joo | - |
dc.identifier.doi | 10.3390/molecules27020334 | - |
dc.identifier.scopusid | 2-s2.0-85122248192 | - |
dc.identifier.wosid | 000746946200001 | - |
dc.identifier.bibliographicCitation | MOLECULES, v.27, no.2 | - |
dc.relation.isPartOf | MOLECULES | - |
dc.citation.title | MOLECULES | - |
dc.citation.volume | 27 | - |
dc.citation.number | 2 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | - |
dc.subject.keywordPlus | PLASMA LEPTIN LEVELS | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | FETUIN-A | - |
dc.subject.keywordPlus | CARDIOVASCULAR-DISEASE | - |
dc.subject.keywordPlus | ADIPONECTIN RECEPTORS | - |
dc.subject.keywordPlus | HEART-FAILURE | - |
dc.subject.keywordPlus | VISCERAL FAT | - |
dc.subject.keywordPlus | MYOCARDIAL ISCHEMIA/REPERFUSION | - |
dc.subject.keywordAuthor | adipokine | - |
dc.subject.keywordAuthor | metabolic syndrome | - |
dc.subject.keywordAuthor | glucose intolerance | - |
dc.subject.keywordAuthor | lipid metabolism | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.